公司资料
Takeda 股价、新闻与催化剂
- 股票代码:
- TAK
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- Japan and listed in the U
股票表现
17.38 USD (-1.42%)
收盘价
最后更新: 2026年8月17日
48B USD
市值
股价为何变动
As of Aug 17, 2026, TAK closed down 1.42% at $17.38. No new same-company headline was identified in the current news window.
公司概览
业务概览
Takeda is a global pharmaceutical company with broad exposure to gastroenterology, oncology, rare disease, plasma-derived therapies, and vaccines. Its business is defined by scale, diversification, and a strong international footprint.
所在地与行业分类
Takeda is headquartered in Japan and listed in the U.S. market. It sits in global large-cap pharma rather than biotech.
商业模式特征
The company generates value through branded medicines, portfolio diversification, and disciplined R&D reinvestment. Investors watch pipeline progress, earnings stability, and geographic breadth.
生物医药行业定位
Takeda sits in the top tier of global pharma. It is less binary than biotech, but its pipeline and launch cadence still matter to the market.
未来催化剂
- Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve. The company will be watched for broad commercial stability.
近期新闻
- 01
- 02
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。